225 related articles for article (PubMed ID: 30571316)
21. Role of thrombospondin-1 in control of von Willebrand factor multimer size in mice.
Pimanda JE; Ganderton T; Maekawa A; Yap CL; Lawler J; Kershaw G; Chesterman CN; Hogg PJ
J Biol Chem; 2004 May; 279(20):21439-48. PubMed ID: 14981081
[TBL] [Abstract][Full Text] [Related]
22. Size regulation of von Willebrand factor-mediated platelet thrombi by ADAMTS13 in flowing blood.
Donadelli R; Orje JN; Capoferri C; Remuzzi G; Ruggeri ZM
Blood; 2006 Mar; 107(5):1943-50. PubMed ID: 16293606
[TBL] [Abstract][Full Text] [Related]
23. [Biology of von Willebrand factor].
Girma JP
Nephrol Ther; 2006 Jan; 2 Suppl 2():S143-8. PubMed ID: 17373215
[TBL] [Abstract][Full Text] [Related]
24. Balance between von Willebrand factor and ADAMTS13 following major partial hepatectomy.
Groeneveld DJ; Alkozai EM; Adelmeijer J; Porte RJ; Lisman T
Br J Surg; 2016 May; 103(6):735-743. PubMed ID: 27005894
[TBL] [Abstract][Full Text] [Related]
25. Turbulent Flow Promotes Cleavage of VWF (von Willebrand Factor) by ADAMTS13 (A Disintegrin and Metalloproteinase With a Thrombospondin Type-1 Motif, Member 13).
Bortot M; Ashworth K; Sharifi A; Walker F; Crawford NC; Neeves KB; Bark D; Di Paola J
Arterioscler Thromb Vasc Biol; 2019 Sep; 39(9):1831-1842. PubMed ID: 31291760
[TBL] [Abstract][Full Text] [Related]
26. High shear dependent von Willebrand factor self-assembly fostered by platelet interaction and controlled by ADAMTS13.
Kragh T; Napoleone M; Fallah MA; Gritsch H; Schneider MF; Reininger AJ
Thromb Res; 2014 Jun; 133(6):1079-87. PubMed ID: 24681085
[TBL] [Abstract][Full Text] [Related]
27. ADAMTS13 reduces VWF-mediated acute inflammation following focal cerebral ischemia in mice.
Khan MM; Motto DG; Lentz SR; Chauhan AK
J Thromb Haemost; 2012 Aug; 10(8):1665-71. PubMed ID: 22712744
[TBL] [Abstract][Full Text] [Related]
28. Recombinant Human ADAMTS13 Treatment Improves Myocardial Remodeling and Functionality After Pressure Overload Injury in Mice.
Witsch T; Martinod K; Sorvillo N; Portier I; De Meyer SF; Wagner DD
J Am Heart Assoc; 2018 Jan; 7(3):. PubMed ID: 29367415
[TBL] [Abstract][Full Text] [Related]
29. Modulation of the von Willebrand factor-dependent platelet adhesion through alternative proteolytic pathways.
Wohner N; Kovács A; Machovich R; Kolev K
Thromb Res; 2012 Apr; 129(4):e41-6. PubMed ID: 22178067
[TBL] [Abstract][Full Text] [Related]
30. Structure and function of snake venom toxins interacting with human von Willebrand factor.
Matsui T; Hamako J
Toxicon; 2005 Jun; 45(8):1075-87. PubMed ID: 15922776
[TBL] [Abstract][Full Text] [Related]
31. Shear stress and von Willebrand factor in health and disease.
Tsai HM
Semin Thromb Hemost; 2003 Oct; 29(5):479-88. PubMed ID: 14631548
[TBL] [Abstract][Full Text] [Related]
32. ADAMTS13-von Willebrand factor axis is involved in the pathophysiology of kidney ischaemia-reperfusion injury.
Kim MG; Lim SY; Ko YS; Lee HY; Jo SK; Cho WY
Nephrology (Carlton); 2017 Nov; 22(11):913-920. PubMed ID: 27507004
[TBL] [Abstract][Full Text] [Related]
33. Higher and lower active circulating VWF levels: different facets of von Willebrand disease.
Casonato A; Pontara E; Morpurgo M; Sartorello F; De Groot PG; Cattini MG; Daidone V; De Marco L
Br J Haematol; 2015 Dec; 171(5):845-53. PubMed ID: 26456374
[TBL] [Abstract][Full Text] [Related]
34. The p.R1819_C1948delinsS mutation makes von Willebrand factor ADAMTS13-resistant and reduces its collagen-binding capacity.
Daidone V; Saga G; Barbon G; Pontara E; Cattini MG; Morpurgo M; Zanotti G; Casonato A
Br J Haematol; 2015 Aug; 170(4):564-73. PubMed ID: 25904363
[TBL] [Abstract][Full Text] [Related]
35. Von Willebrand Factor Aggravates Hepatic Ischemia-Reperfusion Injury by Promoting Neutrophil Recruitment in Mice.
Urisono Y; Sakata A; Matsui H; Kasuda S; Ono S; Yoshimoto K; Nishio K; Sho M; Akiyama M; Miyata T; Okuchi K; Nishimura S; Sugimoto M
Thromb Haemost; 2018 Apr; 118(4):700-708. PubMed ID: 29618155
[TBL] [Abstract][Full Text] [Related]
36. Ultralarge von Willebrand factor fibers mediate luminal Staphylococcus aureus adhesion to an intact endothelial cell layer under shear stress.
Pappelbaum KI; Gorzelanny C; Grässle S; Suckau J; Laschke MW; Bischoff M; Bauer C; Schorpp-Kistner M; Weidenmaier C; Schneppenheim R; Obser T; Sinha B; Schneider SW
Circulation; 2013 Jul; 128(1):50-9. PubMed ID: 23720451
[TBL] [Abstract][Full Text] [Related]
37. Von Willebrand factor and ADAMTS13 in arterial thrombosis: a systematic review and meta-analysis.
Sonneveld MA; de Maat MP; Leebeek FW
Blood Rev; 2014 Jul; 28(4):167-78. PubMed ID: 24825749
[TBL] [Abstract][Full Text] [Related]
38. The presence of active von Willebrand factor under various pathological conditions.
Groot E; de Groot PG; Fijnheer R; Lenting PJ
Curr Opin Hematol; 2007 May; 14(3):284-9. PubMed ID: 17414220
[TBL] [Abstract][Full Text] [Related]
39. Deficiency of von Willebrand factor protects mice from ischemic stroke.
Kleinschnitz C; De Meyer SF; Schwarz T; Austinat M; Vanhoorelbeke K; Nieswandt B; Deckmyn H; Stoll G
Blood; 2009 Apr; 113(15):3600-3. PubMed ID: 19182208
[TBL] [Abstract][Full Text] [Related]
40. Assessment of the Diagnostic Value of Plasma Levels, Activities, and Their Ratios of von Willebrand Factor and ADAMTS13 in Patients with Cerebral Infarction.
Qu L; Jiang M; Qiu W; Lu S; Zhao Y; Xia L; Ruan C; Zhao Y
Clin Appl Thromb Hemost; 2016 Apr; 22(3):252-9. PubMed ID: 25916953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
